Cargando…
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis
Myelofibrosis (MF) is a myeloproliferative neoplasm (MPN) with heterogeneous clinical course. Allogeneic hematopoietic cell transplantation remains the only curative therapy, but its morbidity and mortality require careful candidate selection. Therefore, accurate disease risk prognostication is crit...
Ejemplares similares
-
Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis
por: García-Fortes, María, et al.
Publicado: (2022) -
Cost-effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain
por: Gómez-Casares, María Teresa, et al.
Publicado: (2017) -
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study
por: Ayala, Rosa, et al.
Publicado: (2023) -
Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping
por: Díaz-González, Álvaro, et al.
Publicado: (2023) -
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
por: Triguero, Ana, et al.
Publicado: (2022)